LIOTHYRONINE SODIUM

LIOTHYRONINE SODIUM was reported 8769 times

LIOTHYRONINE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EJECTION FRACTION 211 0.3632
1 SENSITISATION 260 0.3426
2 POLYCYSTIC OVARIES 262 0.1688
3 TRI-IODOTHYRONINE ABNORMAL 14 0.1157
4 DIFFUSE VASCULITIS 9 0.1000
5 TRI-IODOTHYRONINE INCREASED 37 0.0927
6 TRI-IODOTHYRONINE DECREASED 39 0.0747
7 EJECTION FRACTION ABNORMAL 83 0.0677
8 RHINITIS ALLERGIC 264 0.0592
9 NEPHRECTOMY 85 0.0572
10 THYROXINE ABNORMAL 11 0.0521
11 OBSTRUCTIVE SLEEP APNOEA SYNDROME 62 0.0425
12 POST PROCEDURAL HYPOTHYROIDISM 8 0.0377
13 BLOOD PROLACTIN DECREASED 6 0.0343
14 THYROXINE DECREASED 21 0.0339
15 POLYCYSTIC OVARIAN SYNDROME 12 0.0312
16 REACTION TO EXCIPIENT 52 0.0225
17 PEAK EXPIRATORY FLOW RATE DECREASED 9 0.0205
18 CARPAL TUNNEL SYNDROME 285 0.0203
19 BLOOD TEST ABNORMAL 274 0.0195
20 BLOOD THYROID STIMULATING HORMONE ABNORMAL 35 0.0190
21 THYROXINE FREE DECREASED 10 0.0177
22 BLOOD THYROID STIMULATING HORMONE DECREASED 79 0.0174
23 SLEEP APNOEA SYNDROME 315 0.0165
24 TYPE V HYPERLIPIDAEMIA 8 0.0165
25 REACTION TO DRUG EXCIPIENTS 34 0.0156
26 INSULIN-LIKE GROWTH FACTOR INCREASED 22 0.0154
27 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 256 0.0151
28 LICHEN SCLEROSUS 10 0.0146
29 THYROID FUNCTION TEST ABNORMAL 60 0.0144
30 AUTOIMMUNE THYROIDITIS 53 0.0140
31 HYPOTHYROIDISM 433 0.0135
32 FIBROMYALGIA 329 0.0135
33 GLUTEN SENSITIVITY 19 0.0134
34 ANTI-THYROID ANTIBODY POSITIVE 6 0.0131
35 ANTIBODY TEST ABNORMAL 9 0.0125
36 THYROID HORMONES DECREASED 10 0.0125
37 PRE-EXISTING CONDITION IMPROVED 73 0.0117
38 ALLERGIC REACTION TO EXCIPIENT 23 0.0115
39 THYROXINE INCREASED 8 0.0113
40 SUBCUTANEOUS EMPHYSEMA 11 0.0112
41 PERFORATION 9 0.0112
42 MORNING SICKNESS 6 0.0110
43 CHALAZION 6 0.0094
44 THYROIDECTOMY 16 0.0092
45 IMMUNOGLOBULINS DECREASED 12 0.0087
46 BLOOD THYROID STIMULATING HORMONE INCREASED 75 0.0081
47 ENDOCRINE OPHTHALMOPATHY 7 0.0081
48 MUCOSAL ULCERATION 8 0.0079
49 RECALLED PRODUCT 13 0.0075
50 PAPILLARY THYROID CANCER 13 0.0075
51 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 47 0.0072
52 LYME DISEASE 24 0.0072
53 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 9 0.0067
54 ANAEMIA OF CHRONIC DISEASE 6 0.0066
55 FULL BLOOD COUNT ABNORMAL 69 0.0065
56 PREMATURE MENOPAUSE 6 0.0065
57 COMPLEX REGIONAL PAIN SYNDROME 9 0.0061
58 HYPOGONADISM 6 0.0059
59 COELIAC DISEASE 57 0.0058
60 ADRENAL DISORDER 11 0.0057
61 RENAL DISORDER 256 0.0055
62 INFUSION SITE PRURITUS 17 0.0054
63 MALABSORPTION 28 0.0054
64 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 257 0.0053
65 THYROID DISORDER 82 0.0053
66 HYPERTHYROIDISM 76 0.0052
67 NEPHROPATHY 45 0.0048
68 BURNING SENSATION 336 0.0048
69 WOUND COMPLICATION 16 0.0047
70 ACUTE SINUSITIS 8 0.0046
71 SPONDYLOLISTHESIS 8 0.0046
72 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 325 0.0046
73 INFUSION SITE DISCHARGE 8 0.0046
74 INHIBITORY DRUG INTERACTION 7 0.0044
75 GOITRE 18 0.0044
76 GASTROOESOPHAGEAL REFLUX DISEASE 353 0.0044
77 ESSENTIAL HYPERTENSION 8 0.0044
78 CHRONIC FATIGUE SYNDROME 6 0.0043
79 CONNECTIVE TISSUE DISORDER 6 0.0042
80 MITRAL VALVE PROLAPSE 7 0.0042
81 PRODUCT ADMINISTRATION INTERRUPTED 33 0.0042
82 GASTRIC DILATATION 7 0.0042
83 INFUSION SITE BRUISING 9 0.0042
84 JUDGEMENT IMPAIRED 6 0.0041
85 TONGUE DISCOLOURATION 18 0.0041
86 ADRENOCORTICAL INSUFFICIENCY ACUTE 8 0.0041
87 BLOOD CHLORIDE INCREASED 7 0.0040
88 CLUMSINESS 11 0.0040
89 WHEEZING 237 0.0040
90 SUSPECTED PRODUCT QUALITY ISSUE 7 0.0038
91 LUMBAR SPINAL STENOSIS 11 0.0038
92 FOOD ALLERGY 28 0.0036
93 PERIARTHRITIS 8 0.0035
94 CARDIAC DISORDER 326 0.0035
95 HANGOVER 12 0.0034
96 STRABISMUS 10 0.0034
97 ANIMAL BITE 9 0.0034
98 BLOOD IMMUNOGLOBULIN G DECREASED 8 0.0032
99 TRICHORRHEXIS 9 0.0032
100 ONYCHOCLASIS 22 0.0032
101 ASTHMA 360 0.0032
102 RESPIRATORY SYMPTOM 9 0.0032
103 MENOPAUSE 8 0.0031
104 POSTMENOPAUSAL HAEMORRHAGE 8 0.0031
105 ENERGY INCREASED 18 0.0030
106 SEASONAL ALLERGY 43 0.0030
107 MENOPAUSAL SYMPTOMS 7 0.0030
108 MULTIPLE ALLERGIES 23 0.0029
109 SNORING 11 0.0029
110 PULSE ABNORMAL 7 0.0029
111 IMPAIRED SELF-CARE 6 0.0029
112 WRONG DOSE 7 0.0029
113 INSULIN RESISTANCE 6 0.0029
114 CHOLECYSTITIS INFECTIVE 8 0.0029
115 BODY TEMPERATURE FLUCTUATION 6 0.0029
116 BLOOD TESTOSTERONE INCREASED 6 0.0028
117 SLUGGISHNESS 28 0.0027
118 BIPOLAR I DISORDER 6 0.0027
119 INFUSION SITE SWELLING 17 0.0027
120 IDIOPATHIC INTRACRANIAL HYPERTENSION 6 0.0027
121 HORMONE LEVEL ABNORMAL 13 0.0027
122 TEMPERATURE INTOLERANCE 27 0.0026
123 MAJOR DEPRESSION 19 0.0026
124 INTERVERTEBRAL DISC DISORDER 11 0.0026
125 FOOD CRAVING 13 0.0025
126 AUTOIMMUNE DISORDER 24 0.0025
127 DEAFNESS NEUROSENSORY 8 0.0024
128 CARTILAGE INJURY 6 0.0024
129 ARTHROPOD BITE 18 0.0024
130 HYPERACUSIS 9 0.0024
131 CHRONIC SINUSITIS 9 0.0024
132 NECK INJURY 7 0.0024
133 NERVE COMPRESSION 22 0.0024
134 VITAMIN D DECREASED 20 0.0023
135 LOSS OF EMPLOYMENT 7 0.0023
136 SUSPECTED COUNTERFEIT PRODUCT 9 0.0023
137 PALPITATIONS 263 0.0022
138 HYPERTENSION 471 0.0022
139 DIABETIC NEUROPATHY 11 0.0022
140 HYPERSOMNIA 63 0.0022
141 FOREIGN BODY SENSATION IN EYES 14 0.0022
142 TENDONITIS 34 0.0022
143 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
144 FEELING JITTERY 41 0.0021
145 BODY HEIGHT DECREASED 23 0.0021
146 ROSACEA 10 0.0021
147 PSYCHOMOTOR RETARDATION 6 0.0021
148 BODY TEMPERATURE DECREASED 21 0.0021
149 INFUSION SITE HAEMORRHAGE 7 0.0021
150 SCOLIOSIS 13 0.0021
151 ANXIETY DISORDER 7 0.0021
152 TEARFULNESS 9 0.0021
153 FEELING COLD 58 0.0021
154 THYROID CANCER 25 0.0021
155 AUTONOMIC NERVOUS SYSTEM IMBALANCE 6 0.0021
156 URINE ODOUR ABNORMAL 12 0.0020
157 LIGAMENT RUPTURE 9 0.0020
158 CARDIAC FLUTTER 13 0.0020
159 WEIGHT FLUCTUATION 21 0.0020
160 OBSTRUCTION 8 0.0020
161 HYPERKERATOSIS 11 0.0020
162 PSYCHOMOTOR HYPERACTIVITY 33 0.0020
163 LOGORRHOEA 7 0.0020
164 WEIGHT INCREASED 443 0.0020
165 SPINAL FUSION SURGERY 8 0.0020
166 WEIGHT LOSS POOR 10 0.0020
167 NEPHROGENIC ANAEMIA 9 0.0019
168 THERAPEUTIC RESPONSE UNEXPECTED 87 0.0019
169 HUNGER 27 0.0019
170 DERMATITIS CONTACT 22 0.0019
171 BLOOD PHOSPHORUS DECREASED 7 0.0019
172 NASAL DRYNESS 12 0.0019
173 VAGINAL INFECTION 9 0.0019
174 PRODUCT SUBSTITUTION ISSUE 110 0.0019
175 DRUG EFFECT INCREASED 6 0.0019
176 INFUSION SITE ERYTHEMA 16 0.0019
177 INFUSION SITE PAIN 24 0.0019
178 SINUS HEADACHE 11 0.0018
179 ANTINUCLEAR ANTIBODY POSITIVE 6 0.0018
180 INSURANCE ISSUE 28 0.0018
181 SOMNAMBULISM 12 0.0018
182 PRODUCT ODOUR ABNORMAL 19 0.0018
183 APPETITE DISORDER 12 0.0018
184 PHYSICAL DISABILITY 8 0.0018
185 CONCUSSION 14 0.0018
186 POST-TRAUMATIC STRESS DISORDER 12 0.0018
187 HYPOPHOSPHATAEMIA 13 0.0018
188 BLOOD TESTOSTERONE DECREASED 12 0.0018
189 EAR DISCOMFORT 18 0.0018
190 FEELING ABNORMAL 420 0.0018
191 BIPOLAR DISORDER 19 0.0017
192 SKIN PAPILLOMA 7 0.0017
193 MIGRAINE 166 0.0017
194 MUSCLE STRAIN 15 0.0017
195 PERIORBITAL OEDEMA 9 0.0017
196 ADRENAL INSUFFICIENCY 21 0.0017
197 MATERNAL EXPOSURE DURING BREAST FEEDING 7 0.0017
198 BRAIN FOG 27 0.0017
199 FEELING OF BODY TEMPERATURE CHANGE 10 0.0017
200 EAR PAIN 33 0.0017
201 SCAR 29 0.0017
202 SPINAL COLUMN STENOSIS 8 0.0017
203 SINUSITIS 173 0.0017
204 APPENDICECTOMY 6 0.0017
205 BRUXISM 9 0.0017
206 PRODUCT FORMULATION ISSUE 11 0.0017
207 MUSCLE TIGHTNESS 27 0.0017
208 ACTIVITIES OF DAILY LIVING IMPAIRED 33 0.0017
209 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
210 UTERINE LEIOMYOMA 12 0.0016
211 EYE SWELLING 61 0.0016
212 OSTEOARTHRITIS 69 0.0016
213 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
214 PRODUCT TASTE ABNORMAL 22 0.0016
215 LIGAMENT SPRAIN 16 0.0016
216 INFUSION SITE EXTRAVASATION 10 0.0016
217 PROTEIN URINE PRESENT 8 0.0016
218 DYSPHEMIA 7 0.0016
219 ONYCHOMYCOSIS 7 0.0016
220 HEART RATE INCREASED 157 0.0016
221 DRUG TOLERANCE 8 0.0016
222 ALOPECIA 309 0.0016
223 HAIR TEXTURE ABNORMAL 21 0.0016
224 EXERCISE TOLERANCE DECREASED 9 0.0016
225 HERPES VIRUS INFECTION 9 0.0016
226 MADAROSIS 18 0.0015
227 EATING DISORDER 33 0.0015
228 PANIC DISORDER 6 0.0015
229 POOR VENOUS ACCESS 16 0.0015
230 INCOHERENT 10 0.0015
231 SENSATION OF FOREIGN BODY 13 0.0015
232 VITAMIN D DEFICIENCY 15 0.0015
233 PERIPHERAL COLDNESS 21 0.0015
234 SEDATION 40 0.0015
235 AFFECTIVE DISORDER 12 0.0015
236 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
237 POOR QUALITY PRODUCT ADMINISTERED 16 0.0015
238 OSTEOPENIA 23 0.0015
239 SINUS DISORDER 30 0.0015
240 ABDOMINAL DISTENSION 157 0.0015
241 THINKING ABNORMAL 28 0.0015
242 CARDIAC MURMUR 13 0.0015
243 BLEPHARITIS 6 0.0015
244 CANDIDIASIS 6 0.0015
245 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
246 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
247 EYE PAIN 84 0.0015
248 ENURESIS 6 0.0015
249 FRUSTRATION TOLERANCE DECREASED 12 0.0015
250 PANIC ATTACK 54 0.0015
251 TOOTH ABSCESS 15 0.0015
252 PRE-ECLAMPSIA 7 0.0015
253 BACK INJURY 16 0.0015
254 PRODUCT DISPENSING ERROR 32 0.0015
255 INCREASED APPETITE 28 0.0015
256 MENISCUS INJURY 9 0.0015
257 LIMB OPERATION 7 0.0015
258 HAIR DISORDER 12 0.0015
259 VENTRICULAR EXTRASYSTOLES 15 0.0014
260 LARGE INTESTINE POLYP 10 0.0014
261 TOOTH INFECTION 19 0.0014
262 PHOTOPHOBIA 27 0.0014
263 EAR INFECTION 38 0.0014
264 PHOTOPSIA 9 0.0014
265 PANCREATIC DISORDER 7 0.0014
266 THERAPEUTIC RESPONSE CHANGED 9 0.0014
267 COLD SWEAT 25 0.0014
268 HEADACHE 887 0.0014
269 EXPIRED DRUG ADMINISTERED 7 0.0014
270 DEPRESSION 320 0.0014
271 OVARIAN CYST 14 0.0014
272 PARAESTHESIA ORAL 20 0.0014
273 GASTROENTERITIS VIRAL 25 0.0014
274 OCULAR ICTERUS 6 0.0014
275 DRY THROAT 14 0.0014
276 INTERVERTEBRAL DISC PROTRUSION 30 0.0014
277 HEART RATE IRREGULAR 31 0.0014
278 TINNITUS 63 0.0014
279 SPUTUM DISCOLOURED 13 0.0014
280 THROAT TIGHTNESS 37 0.0014
281 WALKING AID USER 9 0.0014
282 PRODUCT COLOUR ISSUE 7 0.0014
283 LABORATORY TEST ABNORMAL 40 0.0014
284 INSOMNIA 361 0.0014
285 BACK DISORDER 22 0.0014
286 CARDIAC FAILURE ACUTE 9 0.0013
287 MYOSITIS 12 0.0013
288 SINUS CONGESTION 18 0.0013
289 ILLNESS 137 0.0013
290 MENSTRUAL DISORDER 11 0.0013
291 IMPAIRED DRIVING ABILITY 15 0.0013
292 OBESITY 21 0.0013
293 CHOLECYSTECTOMY 15 0.0013
294 INTENTIONAL PRODUCT USE ISSUE 115 0.0013
295 IRON DEFICIENCY ANAEMIA 12 0.0013
296 SPINAL OPERATION 16 0.0013
297 DISTURBANCE IN ATTENTION 70 0.0013
298 STRESS FRACTURE 7 0.0013
299 ERYTHEMA OF EYELID 7 0.0013
300 NECK PAIN 72 0.0013
301 SKIN LACERATION 14 0.0013
302 PRODUCT PHYSICAL CONSISTENCY ISSUE 7 0.0013
303 NERVOUSNESS 66 0.0013
304 ENDOMETRIOSIS 6 0.0013
305 NAIL DISORDER 11 0.0013
306 HEART RATE ABNORMAL 7 0.0013
307 BLOOD CALCIUM INCREASED 11 0.0013
308 SPINAL OSTEOARTHRITIS 11 0.0013
309 MALNUTRITION 14 0.0013
310 OCULAR DISCOMFORT 14 0.0012
311 SUICIDAL IDEATION 113 0.0012
312 NEURALGIA 30 0.0012
313 ABNORMAL DREAMS 34 0.0012
314 PHARYNGEAL SWELLING 12 0.0012
315 MICTURITION URGENCY 14 0.0012
316 DRY EYE 61 0.0012
317 ABNORMAL FAECES 10 0.0012
318 HYPERHIDROSIS 157 0.0012
319 LETHARGY 70 0.0012
320 SKIN HAEMORRHAGE 18 0.0012
321 DISABILITY 24 0.0012
322 TREMOR 201 0.0012
323 GASTROINTESTINAL SOUNDS ABNORMAL 6 0.0012
324 PHARYNGITIS 15 0.0012
325 DRY MOUTH 98 0.0012
326 HYPERVENTILATION 7 0.0012
327 METABOLIC DISORDER 7 0.0012
328 DECREASED ACTIVITY 13 0.0012
329 SECRETION DISCHARGE 15 0.0012
330 MENTAL IMPAIRMENT 29 0.0012
331 PRODUCTIVE COUGH 57 0.0012
332 PERSONALITY CHANGE 11 0.0012
333 THROAT IRRITATION 53 0.0012
334 ANXIETY 336 0.0012
335 DISSOCIATION 9 0.0012
336 ROTATOR CUFF SYNDROME 15 0.0012
337 IRRITABILITY 70 0.0012
338 OEDEMA 63 0.0012
339 MANIA 19 0.0012
340 RESTLESS LEGS SYNDROME 21 0.0012
341 BONE DISORDER 21 0.0012
342 CHEST DISCOMFORT 118 0.0012
343 ORAL DISCOMFORT 16 0.0012
344 APHONIA 16 0.0011
345 PARTIAL SEIZURES 6 0.0011
346 BEDRIDDEN 15 0.0011
347 FLUID RETENTION 58 0.0011
348 DIZZINESS POSTURAL 11 0.0011
349 THERMAL BURN 8 0.0011
350 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
351 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
352 IRRITABLE BOWEL SYNDROME 24 0.0011
353 DIPLOPIA 29 0.0011
354 ORAL PAIN 25 0.0011
355 PRODUCT SIZE ISSUE 6 0.0011
356 MYASTHENIA GRAVIS 9 0.0011
357 BLEPHAROSPASM 7 0.0011
358 MUSCLE DISORDER 9 0.0011
359 HEART RATE DECREASED 39 0.0011
360 FOOT FRACTURE 21 0.0011
361 FATIGUE 860 0.0011
362 FAECES SOFT 8 0.0011
363 DYSSTASIA 32 0.0011
364 HYPERAESTHESIA 9 0.0011
365 EXOSTOSIS 10 0.0011
366 SKIN LESION 30 0.0011
367 DEAFNESS UNILATERAL 6 0.0011
368 HYPERLIPIDAEMIA 13 0.0011
369 INCREASED TENDENCY TO BRUISE 10 0.0011
370 NIGHT SWEATS 35 0.0011
371 PRESCRIBED OVERDOSE 21 0.0011
372 WRIST FRACTURE 13 0.0011
373 CARDIOMYOPATHY 16 0.0011
374 NERVE INJURY 12 0.0011
375 WEIGHT DECREASED 301 0.0011
376 TENDON DISORDER 7 0.0011
377 INITIAL INSOMNIA 11 0.0011
378 MUSCLE SPASMS 196 0.0011
379 IMMUNE SYSTEM DISORDER 14 0.0011
380 PERIORBITAL SWELLING 6 0.0011
381 UNEVALUABLE EVENT 80 0.0011
382 SWOLLEN TONGUE 33 0.0011
383 GENERALISED OEDEMA 13 0.0010
384 PARAESTHESIA 165 0.0010
385 MYALGIA 178 0.0010
386 MUSCULOSKELETAL DISCOMFORT 18 0.0010
387 PARANOIA 18 0.0010
388 BLOOD MAGNESIUM DECREASED 9 0.0010
389 PRODUCT PHYSICAL ISSUE 21 0.0010
390 PHARYNGEAL OEDEMA 16 0.0010
391 AFFECT LABILITY 10 0.0010
392 METASTASES TO LYMPH NODES 7 0.0010
393 ANGER 35 0.0010
394 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
395 POLLAKIURIA 43 0.0010
396 LIMB INJURY 28 0.0010
397 IMPAIRED WORK ABILITY 22 0.0010
398 MALAISE 451 0.0010
399 ROAD TRAFFIC ACCIDENT 43 0.0010
400 DYSPEPSIA 101 0.0010
401 ADVERSE EVENT 94 0.0010
402 CRYING 37 0.0010
403 ARTHRITIS 80 0.0010
404 PHARYNGITIS STREPTOCOCCAL 11 0.0010
405 JOINT EFFUSION 7 0.0010
406 HAIR GROWTH ABNORMAL 7 0.0010
407 PLEURISY 6 0.0010
408 WRONG DRUG ADMINISTERED 9 0.0010
409 THIRST 18 0.0010
410 BLOOD PRESSURE ABNORMAL 20 0.0010
411 FORMICATION 7 0.0010
412 MUSCULOSKELETAL STIFFNESS 88 0.0010
413 NASAL CONGESTION 59 0.0010
414 NEPHROLITHIASIS 46 0.0010
415 BRAIN INJURY 10 0.0010
416 OSTEOPOROSIS 41 0.0010
417 OROPHARYNGEAL DISCOMFORT 9 0.0010
418 DYSPNOEA 562 0.0010
419 MOOD ALTERED 27 0.0010
420 BURSITIS 12 0.0010
421 NOCTURIA 12 0.0010
422 HAND FRACTURE 7 0.0010
423 BLOOD PRESSURE INCREASED 151 0.0010
424 JOINT INJURY 21 0.0010
425 PRODUCT SUPPLY ISSUE 7 0.0010
426 URTICARIA 164 0.0010
427 MUSCULAR WEAKNESS 111 0.0010
428 LOCAL SWELLING 17 0.0010
429 RIB FRACTURE 20 0.0010
430 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
431 GASTROINTESTINAL DISORDER 87 0.0010
432 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
433 PRODUCT DISTRIBUTION ISSUE 9 0.0010
434 PANIC REACTION 7 0.0010
435 LIMB DISCOMFORT 30 0.0010
436 SPINAL COMPRESSION FRACTURE 8 0.0010
437 MIDDLE INSOMNIA 18 0.0010
438 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
439 AGEUSIA 24 0.0010
440 HEAD DISCOMFORT 17 0.0010
441 SOMNOLENCE 193 0.0010
442 DYSPHONIA 56 0.0010
443 ORAL DISORDER 7 0.0010
444 IMPAIRED GASTRIC EMPTYING 13 0.0010
445 PAIN IN JAW 27 0.0010
446 GLYCOSYLATED HAEMOGLOBIN INCREASED 24 0.0009
447 HEAD INJURY 30 0.0009
448 MUSCLE ATROPHY 12 0.0009
449 BRONCHITIS 70 0.0009
450 HYPERSENSITIVITY 175 0.0009
451 COGNITIVE DISORDER 44 0.0009
452 SCIATICA 15 0.0009
453 SWELLING 88 0.0009
454 BLOOD PRESSURE DECREASED 62 0.0009
455 HEREDITARY ANGIOEDEMA 10 0.0009
456 ERUCTATION 18 0.0009
457 BREAST TENDERNESS 7 0.0009
458 POOR QUALITY SLEEP 20 0.0009
459 POOR QUALITY DRUG ADMINISTERED 6 0.0009
460 DEPRESSED MOOD 49 0.0009
461 TENDON PAIN 7 0.0009
462 HYSTERECTOMY 8 0.0009
463 CHOKING 18 0.0009
464 SWELLING FACE 60 0.0009
465 SURGERY 54 0.0009
466 SKIN FISSURES 18 0.0009
467 ORTHOSTATIC HYPOTENSION 16 0.0009
468 CONSTIPATION 200 0.0009
469 MUCOSAL INFLAMMATION 24 0.0009
470 BLOOD PRESSURE FLUCTUATION 22 0.0009
471 POLYP 6 0.0009
472 DRUG DISPENSING ERROR 14 0.0009
473 URINE OUTPUT DECREASED 8 0.0009
474 FEELING HOT 56 0.0009
475 ANHEDONIA 24 0.0009
476 GROIN PAIN 8 0.0009
477 CYSTITIS 29 0.0009
478 DYSGRAPHIA 6 0.0009
479 VISION BLURRED 125 0.0009
480 OROPHARYNGEAL PAIN 84 0.0009
481 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
482 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
483 BLOOD SODIUM DECREASED 17 0.0009
484 SKIN DISORDER 30 0.0009
485 FLATULENCE 51 0.0009
486 ASTHENIA 338 0.0009
487 HYPOCALCAEMIA 17 0.0009
488 BLOOD POTASSIUM DECREASED 27 0.0009
489 CHOLECYSTITIS CHRONIC 6 0.0009
490 FACIAL PAIN 8 0.0009
491 LACRIMATION INCREASED 27 0.0009
492 GOUT 16 0.0009
493 HOSPITALISATION 137 0.0009
494 BLOOD CALCIUM DECREASED 10 0.0009
495 PRODUCT USE COMPLAINT 14 0.0009
496 CANDIDA INFECTION 15 0.0009
497 CHEST PAIN 164 0.0009
498 LOWER LIMB FRACTURE 17 0.0009
499 HAIR COLOUR CHANGES 11 0.0009
500 TOOTH EXTRACTION 11 0.0009
501 PRODUCT QUALITY ISSUE 120 0.0009
502 NASAL DISCOMFORT 7 0.0009
503 DISEASE RECURRENCE 42 0.0009
504 RENAL CYST 7 0.0009
505 RESPIRATORY TRACT CONGESTION 14 0.0009
506 TRICUSPID VALVE INCOMPETENCE 7 0.0009
507 ULCER 14 0.0009
508 DRUG INTOLERANCE 85 0.0009
509 BLOOD CHOLESTEROL INCREASED 41 0.0009
510 PRURITUS GENERALISED 19 0.0009
511 SLEEP DISORDER 62 0.0009
512 MOOD SWINGS 28 0.0009
513 ATRIAL FLUTTER 7 0.0009
514 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
515 INFLUENZA LIKE ILLNESS 72 0.0009
516 OEDEMA PERIPHERAL 106 0.0009
517 RHINITIS 7 0.0009
518 APHASIA 26 0.0009
519 AMNESIA 56 0.0009
520 MASS 12 0.0009
521 URINARY TRACT INFECTION 146 0.0009
522 FLUSHING 87 0.0009
523 INJECTION SITE DISCOMFORT 9 0.0009
524 DRUG EFFECT DECREASED 46 0.0009
525 VERTIGO 52 0.0009
526 SPINAL DISORDER 8 0.0008
527 BREAST PAIN 9 0.0008
528 BLOOD IRON DECREASED 10 0.0008
529 LIP SWELLING 28 0.0008
530 ABDOMINAL DISCOMFORT 141 0.0008
531 MUSCULOSKELETAL CHEST PAIN 13 0.0008
532 ANKLE FRACTURE 13 0.0008
533 EYE INFLAMMATION 8 0.0008
534 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
535 IMPAIRED QUALITY OF LIFE 12 0.0008
536 BODY TEMPERATURE INCREASED 17 0.0008
537 HYPERCHOLESTEROLAEMIA 8 0.0008
538 HYPOAESTHESIA 124 0.0008
539 MENTAL DISORDER 36 0.0008
540 HYPOKINESIA 12 0.0008
541 MUSCLE TWITCHING 19 0.0008
542 GASTROENTERITIS 12 0.0008
543 ORAL HERPES 16 0.0008
544 GASTROINTESTINAL PAIN 9 0.0008
545 PERIPHERAL SWELLING 126 0.0008
546 EYE IRRITATION 47 0.0008
547 TOOTH FRACTURE 9 0.0008
548 PSEUDOMONAS INFECTION 7 0.0008
549 FREQUENT BOWEL MOVEMENTS 22 0.0008
550 SMALL INTESTINAL OBSTRUCTION 10 0.0008
551 FOOT DEFORMITY 9 0.0008
552 PSYCHOLOGICAL TRAUMA 7 0.0008
553 EMOTIONAL DISORDER 25 0.0008
554 FUNGAL INFECTION 27 0.0008
555 SENSORY DISTURBANCE 13 0.0008
556 HYPERCALCAEMIA 10 0.0008
557 WITHDRAWAL SYNDROME 34 0.0008
558 HOT FLUSH 61 0.0008
559 FEELING DRUNK 6 0.0008
560 HAEMATOCRIT DECREASED 16 0.0008
561 SKIN SWELLING 7 0.0008
562 DIZZINESS 402 0.0008
563 COVID-19 141 0.0008
564 ARTHRALGIA 333 0.0008
565 PAIN 491 0.0008
566 CHROMATURIA 18 0.0008
567 RETCHING 17 0.0008
568 MITRAL VALVE INCOMPETENCE 9 0.0008
569 GAIT DISTURBANCE 152 0.0008
570 BACK PAIN 184 0.0008
571 ECONOMIC PROBLEM 12 0.0008
572 NEEDLE ISSUE 23 0.0008
573 BONE PAIN 46 0.0008
574 BOWEL MOVEMENT IRREGULARITY 6 0.0008
575 MUSCULOSKELETAL PAIN 41 0.0008
576 SPEECH DISORDER 41 0.0008
577 HYPOPHAGIA 20 0.0008
578 EUPHORIC MOOD 8 0.0008
579 MYDRIASIS 10 0.0008
580 NEUROPATHY PERIPHERAL 74 0.0008
581 PAIN IN EXTREMITY 229 0.0008
582 BALANCE DISORDER 67 0.0008
583 OSTEOMYELITIS 14 0.0008
584 DELUSION 12 0.0008
585 RED BLOOD CELL COUNT DECREASED 22 0.0008
586 HAEMORRHOIDS 15 0.0008
587 RESPIRATORY TRACT INFECTION 20 0.0008
588 ABDOMINAL PAIN UPPER 158 0.0008
589 GASTROINTESTINAL INFLAMMATION 6 0.0008
590 INTENTIONAL PRODUCT MISUSE 67 0.0008
591 EYE DISORDER 25 0.0008
592 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
593 DYSMENORRHOEA 10 0.0008
594 INFLUENZA 84 0.0008
595 HEPATIC STEATOSIS 14 0.0008
596 VIRAL INFECTION 25 0.0008
597 QUALITY OF LIFE DECREASED 10 0.0007
598 DYSARTHRIA 28 0.0007
599 FEAR 20 0.0007
600 DYSPNOEA EXERTIONAL 28 0.0007
601 NASOPHARYNGITIS 137 0.0007
602 NAUSEA 587 0.0007
603 FEEDING DISORDER 15 0.0007
604 POST PROCEDURAL INFECTION 6 0.0007
605 THERAPEUTIC PRODUCT EFFECT DECREASED 33 0.0007
606 INTENTIONAL DOSE OMISSION 21 0.0007
607 DRUG INEFFECTIVE 969 0.0007
608 MUSCLE SPASTICITY 9 0.0007
609 GINGIVAL BLEEDING 10 0.0007
610 CARDIOMEGALY 9 0.0007
611 TACHYCARDIA 65 0.0007
612 OXYGEN SATURATION DECREASED 41 0.0007
613 POST PROCEDURAL COMPLICATION 14 0.0007
614 GALLBLADDER DISORDER 13 0.0007
615 MEMORY IMPAIRMENT 100 0.0007
616 INJURY 51 0.0007
617 ATELECTASIS 7 0.0007
618 JOINT STIFFNESS 19 0.0007
619 DENTAL CARIES 8 0.0007
620 NIGHTMARE 25 0.0007
621 GASTRITIS 19 0.0007
622 AGITATION 53 0.0007
623 VENTRICULAR FIBRILLATION 8 0.0007
624 CONDITION AGGRAVATED 219 0.0007
625 TOOTHACHE 13 0.0007
626 COUGH 201 0.0007
627 KIDNEY INFECTION 14 0.0007
628 JOINT SWELLING 86 0.0007
629 KNEE OPERATION 7 0.0007
630 DIABETES MELLITUS 54 0.0007
631 BLADDER DISORDER 7 0.0007
632 NERVOUS SYSTEM DISORDER 22 0.0007
633 SINUS TACHYCARDIA 10 0.0007
634 INTRAOCULAR PRESSURE INCREASED 9 0.0007
635 PRODUCT AVAILABILITY ISSUE 16 0.0007
636 OSTEONECROSIS 23 0.0007
637 PRESYNCOPE 17 0.0007
638 HIATUS HERNIA 9 0.0007
639 MYOPATHY 6 0.0007
640 FALL 231 0.0007
641 CHILLS 81 0.0007
642 ECZEMA 36 0.0007
643 LIVER FUNCTION TEST ABNORMAL 20 0.0007
644 DYSGEUSIA 51 0.0007
645 DIVERTICULITIS 19 0.0007
646 DYSURIA 25 0.0007
647 ATRIAL FIBRILLATION 66 0.0007
648 BLOOD POTASSIUM INCREASED 11 0.0007
649 STOMATITIS 41 0.0007
650 GLAUCOMA 13 0.0007
651 OCULAR HYPERAEMIA 32 0.0007
652 EYE DISCHARGE 7 0.0007
653 CATARACT 40 0.0007
654 CHRONIC KIDNEY DISEASE 51 0.0007
655 JOINT RANGE OF MOTION DECREASED 9 0.0007
656 GLOSSODYNIA 15 0.0007
657 MOBILITY DECREASED 48 0.0007
658 LOSS OF LIBIDO 6 0.0007
659 STAPHYLOCOCCAL INFECTION 22 0.0007
660 MOUTH ULCERATION 14 0.0007
661 HYPOAESTHESIA ORAL 10 0.0007
662 INCONTINENCE 7 0.0007
663 DEEP VEIN THROMBOSIS 43 0.0007
664 CORONARY ARTERY DISEASE 20 0.0007
665 RENAL PAIN 7 0.0007
666 BLOOD UREA INCREASED 11 0.0007
667 CONTUSION 63 0.0007
668 MOVEMENT DISORDER 21 0.0007
669 DYSPHAGIA 62 0.0007
670 HIP ARTHROPLASTY 10 0.0007
671 UPPER LIMB FRACTURE 13 0.0007
672 LYMPHADENOPATHY 23 0.0006
673 DEVICE RELATED INFECTION 10 0.0006
674 PROCEDURAL PAIN 18 0.0006
675 VISUAL IMPAIRMENT 80 0.0006
676 PRODUCT DOSE OMISSION ISSUE 189 0.0006
677 INFECTION 93 0.0006
678 DEFORMITY 6 0.0006
679 GASTRIC DISORDER 22 0.0006
680 WOUND INFECTION 7 0.0006
681 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 115 0.0006
682 DRY SKIN 85 0.0006
683 RHINORRHOEA 41 0.0006
684 INFUSION RELATED REACTION 42 0.0006
685 BLOOD URINE PRESENT 12 0.0006
686 PRODUCT PACKAGING ISSUE 6 0.0006
687 ABNORMAL BEHAVIOUR 25 0.0006
688 MULTIPLE SCLEROSIS 30 0.0006
689 SKIN INFECTION 7 0.0006
690 DISCOMFORT 38 0.0006
691 ANOSMIA 9 0.0006
692 TREATMENT NONCOMPLIANCE 34 0.0006
693 HERNIA 12 0.0006
694 EYE INFECTION 7 0.0006
695 REBOUND EFFECT 7 0.0006
696 CONFUSIONAL STATE 100 0.0006
697 HYPOGLYCAEMIA 30 0.0006
698 APATHY 9 0.0006
699 PSORIATIC ARTHROPATHY 25 0.0006
700 BLINDNESS 25 0.0006
701 NODULE 8 0.0006
702 ARRHYTHMIA 29 0.0006
703 INJECTION SITE URTICARIA 15 0.0006
704 MENORRHAGIA 12 0.0006
705 SKIN DISCOLOURATION 28 0.0006
706 PRURITUS 234 0.0006
707 URINARY INCONTINENCE 18 0.0006
708 ABASIA 15 0.0006
709 PHOTOSENSITIVITY REACTION 10 0.0006
710 BLISTER 34 0.0006
711 DIARRHOEA 390 0.0006
712 VISUAL ACUITY REDUCED 20 0.0006
713 CAESAREAN SECTION 7 0.0006
714 SPINAL FRACTURE 12 0.0006
715 PAIN OF SKIN 16 0.0006
716 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
717 TASTE DISORDER 12 0.0006
718 DYSKINESIA 24 0.0006
719 RHEUMATOID ARTHRITIS 67 0.0006
720 NEUTROPHIL COUNT INCREASED 6 0.0006
721 INFLAMMATION 30 0.0006
722 RASH PAPULAR 13 0.0006
723 SYNCOPE 58 0.0006
724 RASH GENERALISED 15 0.0006
725 PHARMACEUTICAL PRODUCT COMPLAINT 15 0.0006
726 DEHYDRATION 77 0.0006
727 HERPES ZOSTER 33 0.0006
728 COORDINATION ABNORMAL 8 0.0006
729 HEPATIC ENZYME INCREASED 39 0.0006
730 KNEE ARTHROPLASTY 12 0.0006
731 SKIN REACTION 8 0.0006
732 ABDOMINAL PAIN 132 0.0006
733 BLINDNESS UNILATERAL 8 0.0006
734 HALLUCINATION, AUDITORY 9 0.0006
735 LYMPHOCYTE COUNT DECREASED 10 0.0006
736 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
737 RASH ERYTHEMATOUS 27 0.0006
738 BRONCHOSPASM 8 0.0006
739 DERMATITIS ALLERGIC 7 0.0006
740 DRUG ADMINISTRATION ERROR 17 0.0006
741 ABDOMINAL PAIN LOWER 14 0.0006
742 RASH PRURITIC 30 0.0006
743 DRUG EFFECT INCOMPLETE 20 0.0006
744 IMPAIRED HEALING 18 0.0005
745 RESTLESSNESS 20 0.0005
746 ANOREXIA 7 0.0005
747 THERAPEUTIC RESPONSE SHORTENED 18 0.0005
748 DECREASED APPETITE 126 0.0005
749 VOMITING 255 0.0005
750 INJECTION SITE MASS 20 0.0005
751 EXPOSURE VIA SKIN CONTACT 14 0.0005
752 TOOTH DISORDER 12 0.0005
753 RASH 235 0.0005
754 HYPOACUSIS 23 0.0005
755 TARDIVE DYSKINESIA 15 0.0005
756 ORAL CANDIDIASIS 7 0.0005
757 DISORIENTATION 21 0.0005
758 PULMONARY HYPERTENSION 11 0.0005
759 DERMATITIS 11 0.0005
760 EYE HAEMORRHAGE 7 0.0005
761 LOSS OF CONSCIOUSNESS 67 0.0005
762 BLOOD GLUCOSE DECREASED 25 0.0005
763 METASTASES TO LUNG 6 0.0005
764 AKATHISIA 7 0.0005
765 BASAL CELL CARCINOMA 8 0.0005
766 EXPIRED PRODUCT ADMINISTERED 17 0.0005
767 SKIN EXFOLIATION 43 0.0005
768 PSYCHOTIC DISORDER 15 0.0005
769 INJECTION SITE PRURITUS 34 0.0005
770 ANAPHYLACTIC REACTION 28 0.0005
771 ERYTHEMA 104 0.0005
772 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
773 PRODUCT PRESCRIBING ERROR 12 0.0005
774 DEAFNESS 13 0.0005
775 CELLULITIS 25 0.0005
776 APPLICATION SITE ERYTHEMA 13 0.0005
777 SNEEZING 11 0.0005
778 DRUG WITHDRAWAL SYNDROME 43 0.0005
779 PARALYSIS 7 0.0005
780 INJECTION SITE RASH 15 0.0005
781 PRODUCT PREPARATION ERROR 10 0.0005
782 RASH MACULAR 17 0.0005
783 SEIZURE 56 0.0005
784 PRODUCT USE ISSUE 91 0.0005
785 EPISTAXIS 36 0.0005
786 COAGULOPATHY 8 0.0005
787 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
788 EMOTIONAL DISTRESS 58 0.0005
789 EYE PRURITUS 16 0.0005
790 TYPE 2 DIABETES MELLITUS 16 0.0005
791 FACE OEDEMA 8 0.0005
792 GASTRIC ULCER 9 0.0005
793 HEMIPARESIS 8 0.0005
794 WHITE BLOOD CELL COUNT DECREASED 51 0.0005
795 EXTRA DOSE ADMINISTERED 19 0.0005
796 HEPATITIS 12 0.0005
797 SEROTONIN SYNDROME 9 0.0005
798 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17 0.0005
799 SKIN CANCER 10 0.0005
800 SKIN ULCER 12 0.0005
801 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 94 0.0005
802 BLOOD GLUCOSE INCREASED 87 0.0005
803 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
804 INJECTION SITE PAIN 141 0.0005
805 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
806 DIABETIC KETOACIDOSIS 11 0.0005
807 CHOLELITHIASIS 15 0.0005
808 AMENORRHOEA 8 0.0005
809 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
810 PULMONARY CONGESTION 6 0.0005
811 LOCALISED INFECTION 11 0.0005
812 INTESTINAL OBSTRUCTION 17 0.0005
813 THERAPY CESSATION 23 0.0004
814 COLITIS ULCERATIVE 20 0.0004
815 PRODUCT ADMINISTRATION ERROR 9 0.0004
816 PYREXIA 154 0.0004
817 OSTEONECROSIS OF JAW 11 0.0004
818 PRODUCT DOSE OMISSION 29 0.0004
819 PNEUMONIA ASPIRATION 11 0.0004
820 ABSCESS 7 0.0004
821 HYPOTENSION 88 0.0004
822 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
823 HIP FRACTURE 14 0.0004
824 PERICARDIAL EFFUSION 10 0.0004
825 OFF LABEL USE 377 0.0004
826 INTENTIONAL DRUG MISUSE 9 0.0004
827 BACTERIAL INFECTION 8 0.0004
828 ILL-DEFINED DISORDER 26 0.0004
829 VENTRICULAR TACHYCARDIA 7 0.0004
830 FRACTURE 8 0.0004
831 COLITIS 16 0.0004
832 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
833 AGGRESSION 21 0.0004
834 URINARY RETENTION 14 0.0004
835 ANAEMIA 80 0.0004
836 INJECTION SITE ERYTHEMA 52 0.0004
837 INJECTION SITE SWELLING 32 0.0004
838 BLOOD CREATININE INCREASED 27 0.0004
839 PULMONARY EMBOLISM 39 0.0004
840 BREAST CANCER 38 0.0004
841 PALLOR 11 0.0004
842 PULMONARY MASS 6 0.0004
843 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
844 IMMUNODEFICIENCY 6 0.0004
845 CONVULSION 23 0.0004
846 INJECTION SITE BRUISING 32 0.0004
847 THERAPY NON-RESPONDER 18 0.0004
848 DEVICE USE ISSUE 7 0.0004
849 THROMBOSIS 32 0.0004
850 APPLICATION SITE PRURITUS 9 0.0004
851 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
852 HAEMOPTYSIS 11 0.0004
853 INCORRECT DOSE ADMINISTERED 90 0.0004
854 HAEMORRHAGE 41 0.0004
855 THERAPY INTERRUPTED 28 0.0004
856 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
857 DEVICE ISSUE 35 0.0004
858 GAIT INABILITY 13 0.0004
859 SYNOVITIS 7 0.0004
860 FEMUR FRACTURE 12 0.0004
861 EJECTION FRACTION DECREASED 6 0.0004
862 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
863 SEPSIS 43 0.0004
864 HYPERGLYCAEMIA 14 0.0004
865 RENAL FAILURE 51 0.0004
866 END STAGE RENAL DISEASE 7 0.0004
867 UNDERDOSE 28 0.0004
868 ACCIDENTAL OVERDOSE 14 0.0004
869 BLOOD GLUCOSE ABNORMAL 7 0.0004
870 ADVERSE DRUG REACTION 34 0.0004
871 PNEUMOTHORAX 6 0.0004
872 CONJUNCTIVITIS 7 0.0004
873 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
874 MENSTRUATION IRREGULAR 10 0.0004
875 HALLUCINATION 28 0.0004
876 ACNE 28 0.0004
877 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
878 HYPOKALAEMIA 17 0.0004
879 MUSCULOSKELETAL DISORDER 7 0.0004
880 DRUG INTERACTION 58 0.0004
881 INJECTION SITE REACTION 25 0.0004
882 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
883 ARTHROPATHY 20 0.0004
884 PANCREATITIS 19 0.0004
885 WOUND 10 0.0004
886 DEVICE MALFUNCTION 25 0.0004
887 PRODUCT COMPLAINT 9 0.0004
888 PRESCRIBED UNDERDOSE 7 0.0004
889 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
890 PREGNANCY 7 0.0003
891 FULL BLOOD COUNT DECREASED 7 0.0003
892 VAGINAL HAEMORRHAGE 15 0.0003
893 PLEURAL EFFUSION 21 0.0003
894 HAEMATOCHEZIA 19 0.0003
895 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
896 RESPIRATORY DISORDER 10 0.0003
897 NEUTROPENIA 45 0.0003
898 PELVIC PAIN 6 0.0003
899 THERAPEUTIC RESPONSE DECREASED 20 0.0003
900 NEOPLASM MALIGNANT 22 0.0003
901 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
902 PRODUCT USE IN UNAPPROVED INDICATION 81 0.0003
903 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
904 ABORTION SPONTANEOUS 13 0.0003
905 PNEUMONIA 105 0.0003
906 DEVICE LEAKAGE 14 0.0003
907 HAEMOGLOBIN DECREASED 33 0.0003
908 ANGIOEDEMA 14 0.0003
909 LIVER DISORDER 14 0.0003
910 HYPOXIA 11 0.0003
911 ERECTILE DYSFUNCTION 8 0.0003
912 RENAL INJURY 9 0.0003
913 BRADYCARDIA 16 0.0003
914 INJECTION SITE HAEMORRHAGE 24 0.0003
915 BREAST CANCER FEMALE 8 0.0003
916 CARDIAC FAILURE 24 0.0003
917 INJECTION SITE WARMTH 6 0.0003
918 PULMONARY OEDEMA 13 0.0003
919 RESPIRATORY DISTRESS 8 0.0003
920 NEOPLASM PROGRESSION 10 0.0003
921 OVERDOSE 62 0.0003
922 CARDIAC FAILURE CONGESTIVE 23 0.0003
923 GENERAL PHYSICAL HEALTH DETERIORATION 33 0.0003
924 HALLUCINATION, VISUAL 6 0.0003
925 SKIN IRRITATION 13 0.0003
926 SUICIDE ATTEMPT 17 0.0003
927 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
928 LIVER FUNCTION TEST INCREASED 6 0.0003
929 RECTAL HAEMORRHAGE 12 0.0003
930 SKIN BURNING SENSATION 20 0.0003
931 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13 0.0003
932 COMPLETED SUICIDE 23 0.0003
933 PSORIASIS 36 0.0003
934 PRODUCT PRESCRIBING ISSUE 6 0.0003
935 EXPOSURE DURING PREGNANCY 17 0.0003
936 COMA 13 0.0003
937 HAEMATOMA 7 0.0003
938 RASH MACULO-PAPULAR 6 0.0003
939 PANCREATITIS ACUTE 6 0.0003
940 DRUG DOSE OMISSION 44 0.0003
941 DERMATITIS ATOPIC 14 0.0003
942 LUNG DISORDER 13 0.0003
943 MYOCARDIAL INFARCTION 46 0.0003
944 MENTAL STATUS CHANGES 7 0.0003
945 MEDICATION ERROR 14 0.0003
946 HYPONATRAEMIA 14 0.0002
947 ACUTE KIDNEY INJURY 38 0.0002
948 CEREBROVASCULAR ACCIDENT 41 0.0002
949 MULTIPLE SCLEROSIS RELAPSE 16 0.0002
950 CARDIAC ARREST 19 0.0002
951 DEVICE DISLOCATION 10 0.0002
952 HYPERKALAEMIA 8 0.0002
953 BONE DENSITY DECREASED 7 0.0002
954 C-REACTIVE PROTEIN INCREASED 8 0.0002
955 DEMENTIA 6 0.0002
956 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
957 ANGINA PECTORIS 6 0.0002
958 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
959 INTERSTITIAL LUNG DISEASE 10 0.0002
960 HAEMATURIA 7 0.0002
961 DRUG ABUSE 17 0.0002
962 ASCITES 6 0.0002
963 ACUTE MYOCARDIAL INFARCTION 6 0.0002
964 DELIRIUM 7 0.0002
965 DEVICE BREAKAGE 8 0.0002
966 CEREBRAL HAEMORRHAGE 7 0.0002
967 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
968 RENAL IMPAIRMENT 16 0.0002
969 RENAL FAILURE ACUTE 8 0.0002
970 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
971 FEBRILE NEUTROPENIA 12 0.0002
972 RESPIRATORY FAILURE 13 0.0002
973 NO ADVERSE EVENT 32 0.0002
974 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
975 PLATELET COUNT DECREASED 18 0.0002
976 PRODUCT ADHESION ISSUE 6 0.0002
977 SEPTIC SHOCK 7 0.0002
978 INTENTIONAL OVERDOSE 10 0.0002
979 DISEASE PROGRESSION 18 0.0002
980 TOXICITY TO VARIOUS AGENTS 25 0.0001
981 TREATMENT FAILURE 12 0.0001
982 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
983 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
984 DEATH 105 0.0001
985 LEUKOPENIA 6 0.0001
986 PANCYTOPENIA 6 0.0001
987 PRODUCT STORAGE ERROR 9 0.0001
988 DRUG DEPENDENCE 14 0.0001
989 THROMBOCYTOPENIA 7 0.0001